publication venue for
- FPR2 DNA Aptamers for Targeted Therapy of Wound Repair. 142:2238-2248. 2022
- Natural occurrence of autoantibodies against basement membrane proteins in epidermolysis bullosa. 142:2014-2019. 2022
- Read-Through for Nonsense Mutations in Type XVII Collagen-Deficient Junctional Epidermolysis Bullosa. 142:1227-1230.e4. 2022
- Molecular characterization of the response to haploidentical mesenchymal stem cells treatment in recessive dystrophic epidermolysis bullosa patients. 141:S176-S176. 2021
- Oxidative stress imbalance as contributing factor in the establishment of fibrosis in recessive dystrophic epidermolysis bullosa. 139:S631-S631. 2019
- Phase I/II efficacy and safety study of mesenchymal stromal cells in recessive dystrophic epidermolysis bullosa. 139:S236-S236. 2019
- A study of non-melanoma skin cancer in a series of well-characterized patients with Kindler Syndrome (KS). 137:S292-S292. 2017
- Common mechanisms and signaling pathways in fibroblasts of cancer-prone genodermatoses. 137:S295-S295. 2017
- Comparative transcriptomic analysis of fibroblasts from two sisters with discordant severe generalized recessive dystrophic epidermolysis bullosa phenotype reveals new molecular markers associated with disease severity. 137:S212-S212. 2017
- Olfactory receptors in skin. Localization, specific expression pattern and their potential role in wound healing. 137:S221-S221. 2017
- Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes. 137:836-844. 2017
- Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models. 136:136-145. 2016
- Increased Susceptibility to Skin Carcinogenesis Associated with a Spontaneous Mouse Mutation in the Palmitoyl Transferase Zdhhc13 Gene. 135:3133-3143. 2015
- Long-term survival of type XVII collagen revertant cells in an animal model of revertant cell therapy. 134:571-574. 2014
- Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa. 134:2097-2104. 2014
- Long-Term faithful recapitulation of transglutaminase 1-deficient lamellar ichthyosis in a skin-humanized mouse model, and insights from proteomic studies. 132:1918-1921. 2012
- Development of skin-humanized mouse models of Pachyonychia congenita. 131:1053-1060. 2011
- Revertant mosaicism due to second-site mutation in COL7A1 in patient with recessive dystrophic epidermolysis bullosa. 130:2407-2411. 2010
- Assessment of optimal virus-mediated growth factor gene delivery for human cutaneous wound healing enhancement. 128:1565-1575. 2008